|
|
|
Pfizer Inc announced today that Lipitor(R) (atorvastatin calcium) 80 mg significantly reduced the risk of major cardiovascular events, including heart attack and stroke, by 27 percent in patients with heart disease who had previous coronary bypass surgery compared with patients taking the 10 mg...
Full Coverage:
New Analysis Showed That High Dose Lipitor Can Reduce The Risk Of Cardiovascular Events In Bypass...
Pfizer Inc announced that Lipitor® (atorvastatin calcium) 80 mg significantly reduced the risk of major cardiovascular events, including heart attack and stroke, by 27 percent in patients with heart disease who had previous coronary bypass surgery compared with patients taking the 10 mg dose of...
Pfizer says high dose Lipitor cuts bypass surgery risk
New York Pfizer Inc, has announced that Lipitor (atorvastatin calcium) 80 mg significantly reduced the risk of major cardiovascular events, including heart attack and stroke, by 27 per cent in patients with heart disease who had previous coronary bypass surgery compared with patients taking the...
Pfizer's Lipitor reduces cardiovascular risks in bypass surgery patients
Pfizer has announced that Lipitor 80mg significantly reduced the risk of major cardiovascular events, including heart attack and stroke, by 27% in patients with heart disease who had previous coronary bypass surgery compared with patients taking the 10mg dose of Lipitor.
Pfizer's Lipitor reduces cardiovascular risks in bypass surgery patients
Therapeutics Daily ... Datamonitor Pharmaceutical and HealthWire - 22, 2008 Pfizer has announced that Lipitor 80mg significantly reduced the risk of major cardiovascular events, including heart attack and stroke, by 27% in patients with heart disease who had previous...
Pfizer's Lipitor Reduces Cardiovascular Risks in Bypass Surgery Patients
Pfizer has announced that Lipitor 80mg significantly reduced the risk of major cardiovascular events, including heart attack and stroke, by 27% in patients with heart disease who had previous coronary bypass surgery compared with patients taking the 10mg dose of Lipitor.
New Analysis Showed That High Dose Lipitor Can Reduce the Risk of Cardiovascular Events in Bypass...
NEW YORK--(BUSINESS WIRE)--May 21, 2008 - Pfizer Inc announced today that Lipitor(R) (atorvastatin calcium) 80 mg significantly reduced the risk of major cardiovascular events, including heart attack and stroke, by 27 percent in patients with heart...
Aggressive lipid-lowering benefits bypass patients
NEW YORK (Reuters Health) - In patients who have had heart bypass surgery, taking the cholesterol-lowering drug Lipitor at a dose of 80 milligrams per day, rather than 10 milligrams per day, can markedly improve outcomes, new research shows. Major heart-related "events" fell by 27 percent and the...
New Analysis Showed That High Dose Lipitor Can Reduce the Risk of Cardiovascular Events in Bypass...
NEW YORK----Pfizer Inc announced today that Lipitor® 80 mg significantly reduced the risk of major cardiovascular events, including heart attack and stroke, by 27 percent in patients with heart disease who had previous coronary bypass surgery compared with patients taking the 10 mg dose of Lipitor.
New Analysis Showed That High Dose Lipitor Can Reduce the Risk of Cardiovascular Events in Bypass...
NEW YORK-- --Pfizer Inc announced today that Lipitor® (atorvastatin calcium) 80 mg significantly reduced the risk of major cardiovascular events, including heart attack and stroke, by 27 percent in patients with heart disease who had previous coronary bypass surgery compared with patients taking...
Aggressive lipid-lowering benefits bypass patients
NEW YORK (Reuters Health) - In patients who have had heart bypass surgery, taking the cholesterol-lowering drug Lipitor at a dose of 80 milligrams per day, rather than 10 milligrams per day, can markedly improve outcomes, new research shows. Major heart-related "events" fell by 27 percent and the...
Related categories
Health Care, Hospital Care, Medicines & Remedies, Pharmaceuticals, General Hospitals, Patients, Surgery, Pain, Chest Pain, Cardiovascular Symptoms, Diet Aid, Cholesterol Drugs, Pfizer
International Editions
English - US | English - UK | Deutsch | Française | Español | Português | Italiano | Česká | Русский (Russian) | عربي (Arabic) | 中文（简）(Simplified Chinese)Copyright © 2008 Newstin a.s. All rights reserved. 4.2.5,fe-web-4.2.5;commons-4.2.1;api-4.2.1;fe-4.2.3, 10.10.1.27